DNLI Denali Therapeutics Inc.
Healthcare$19.38+3.97%ClosedMarket Cap: $3.08B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$30.80
Target (Median)
$31.00
Target Range
$23.00 - $40.00
Upside from current price: 58.9%
Rating Distribution
1 Strong Buy17 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-05-11 | BTIG | maintain | Buy | Buy |
| 2026-05-08 | Wedbush | maintain | Outperform | Outperform |
| 2026-04-22 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-07 | Baird | maintain | Outperform | Outperform |
| 2026-03-26 | Stifel | maintain | Buy | Buy |
| 2026-03-26 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-26 | Goldman Sachs | maintain | Buy | Buy |
| 2026-03-26 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-25 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.43 | $113.2M | 15 |
| Sun Dec 31 | $-1.00 | $420.2M | 13 |
| Mon Dec 31 | $-0.41 | $550.2M | 11 |
| Tue Dec 31 | $0.86 | $849.3M | 5 |